FDA approves weight-loss drug Zepbound to treat sleep apnea
2024-12-20The Washington Post
The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the ...undefined